Learn how a 25% Pharma tariff could raise U.S. drug costs by nearly $51 billion annually and impact prices significantly.

Despite the PNG award termination, GeoVax anticipates a milestone-rich 2025 across its portfolio. The Company will continue to engage with government and industry partners, pursue clinical trial ...

The company intended to move the drug into late-stage testing ... Obesity treatments have become one of the more promising ...

With ambitious goals in mind, the young biotech company shows no signs of slowing down. Between making their tissue models increasingly more physiologically accurate and developing ties with drug ...

Colossal Biosciences caught our imagination – and elicited memories of "Jurassic Park" – when the Dallas-based biotech company announced back in 2021 it would use cutting-edge genetics editing ...

After biotech company Colossal announced the birth of three pups bearing the DNA signatures of dire wolves, a predator last seen roaming over 10,000 years ago, curiosity has emerged as to how they did ...

Or, maybe, it's just a grey wolf with a few tweaks. American biotech company Colossal Biosciences made a surprise announcement Monday, claiming it had brought the dire wolf back from the dead ...

The U.S.-based biotechnology company is also known for its ambitious goal of bringing back the extinct woolly mammoth by 2028. This dire wolf pup is among the first of its species born in around ...